• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将性激素和相关药物重新用于治疗帕金森病的潜在治疗方法。

Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.

机构信息

Neuroscience Research Unit, Centre Hospitalier Universitaire de Québec, CHUL, Quebec City, G1V 4G2, Canada; Faculty of Pharmacy, Université Laval, Quebec City, G1K 7P4, Canada.

Neuroscience Research Unit, Centre Hospitalier Universitaire de Québec, CHUL, Quebec City, G1V 4G2, Canada.

出版信息

Neuropharmacology. 2019 Mar 15;147:37-54. doi: 10.1016/j.neuropharm.2018.04.005. Epub 2018 Apr 9.

DOI:10.1016/j.neuropharm.2018.04.005
PMID:29649433
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder for which a greater prevalence and incidence is described in men. This suggests a protective effect of sex hormones in the brain. Therefore, steroids and drugs to treat endocrine conditions could have additional application for PD. Here, we review the protective effect of sex hormones, particularly estrogens, progesterone, androgens and dehydroepiandrosterone, in animal models of PD and also in human studies. Data also support that drugs affecting estrogen neurotransmission such as selective estrogen receptor modulators or affecting steroid metabolism with 5α-reductase inhibitors could be repositioned for treatment of PD. Sex steroids are also modulator of neurotransmission, thus they could repurposed to treat PD motor symptoms and to modulate the response to PD medication. No drug is yet available to limit PD progression. PD is a complex disease implicating multiple pathological processes and a therapeutic strategy using drugs with several mechanisms of action, such as sex steroids and endocrine drugs are interesting repositioning options for symptomatic treatment and disease-modifying activity for PD. This article is part of the Special Issue entitled 'Drug Repurposing: old molecules, new ways to fast track drug discovery and development for CNS disorders'.

摘要

帕金森病(PD)是一种神经退行性疾病,男性的患病率和发病率更高。这表明大脑中的性激素具有保护作用。因此,类固醇和治疗内分泌疾病的药物可能对 PD 有额外的应用。在这里,我们回顾了性激素(特别是雌激素、孕激素、雄激素和脱氢表雄酮)在 PD 动物模型中的保护作用,以及在人类研究中的作用。数据还支持,影响雌激素神经递质传递的药物,如选择性雌激素受体调节剂,或影响类固醇代谢的 5α-还原酶抑制剂,可以重新用于治疗 PD。性激素也是神经递质的调节剂,因此它们可以被重新用于治疗 PD 的运动症状,并调节对 PD 药物的反应。目前还没有药物可以限制 PD 的进展。PD 是一种复杂的疾病,涉及多种病理过程,使用具有多种作用机制的药物(如性激素和内分泌药物)的治疗策略是一种有前途的治疗方法,可用于治疗 PD 的症状和疾病修饰活性。本文是题为“药物再利用:旧分子,快速发现和开发 CNS 疾病新药的新途径”的特刊的一部分。

相似文献

1
Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.将性激素和相关药物重新用于治疗帕金森病的潜在治疗方法。
Neuropharmacology. 2019 Mar 15;147:37-54. doi: 10.1016/j.neuropharm.2018.04.005. Epub 2018 Apr 9.
2
Neuroactive steroids and Parkinson's disease: Review of human and animal studies.神经活性甾体和帕金森病:人体和动物研究综述。
Neurosci Biobehav Rev. 2024 Jan;156:105479. doi: 10.1016/j.neubiorev.2023.105479. Epub 2023 Nov 23.
3
Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.神经活性性腺药物在帕金森病男性和女性模型中的神经保护作用。
Neurosci Biobehav Rev. 2016 Aug;67:79-88. doi: 10.1016/j.neubiorev.2015.09.024. Epub 2015 Dec 17.
4
Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.独立于系统和中枢来源的性激素对帕金森病大鼠模型的影响:雌激素对性别特异性神经保护的贡献。
Horm Behav. 2010 Jan;57(1):23-34. doi: 10.1016/j.yhbeh.2009.06.002. Epub 2009 Jun 16.
5
Old wines in new bottles: Repurposing opportunities for Parkinson's disease.旧酒换新瓶:帕金森病的再利用机会。
Eur J Pharmacol. 2018 Jul 5;830:115-127. doi: 10.1016/j.ejphar.2018.04.023. Epub 2018 Apr 22.
6
Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.重新利用药物治疗帕金森病中 l-DOPA 诱导的运动障碍。
Neuropharmacology. 2019 Mar 15;147:11-27. doi: 10.1016/j.neuropharm.2018.05.035. Epub 2018 Jun 1.
7
Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models.雄激素与帕金森病:人体研究及动物模型综述
Androg Clin Res Ther. 2021 Dec 23;2(1):294-303. doi: 10.1089/andro.2021.0011. eCollection 2021.
8
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.雌激素和选择性雌激素受体调节剂在帕金森病动物模型中的神经保护作用
Mol Cell Endocrinol. 2008 Aug 13;290(1-2):60-9. doi: 10.1016/j.mce.2008.04.008. Epub 2008 Apr 22.
9
Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats.将类固醇生成抑制剂重新用于神经精神疾病的治疗:前景与警示。
Neuropharmacology. 2019 Mar 15;147:55-65. doi: 10.1016/j.neuropharm.2018.05.013. Epub 2018 May 11.
10
CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.中枢神经系统再利用——老药新用的潜力:用于治疗阿尔茨海默病、帕金森病和痉挛的药物筛选实例。
Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27.

引用本文的文献

1
Revisiting the role of steroidal therapeutics in the 21st century: an update on FDA approved steroidal drugs (2000-2024).重新审视甾体疗法在21世纪的作用:美国食品药品监督管理局批准的甾体药物(2000 - 2024年)最新情况
RSC Med Chem. 2025 May 8. doi: 10.1039/d5md00027k.
2
Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021.到2050年195个国家和地区帕金森病患病率及其驱动因素的预测:2021年全球疾病负担研究的建模研究
BMJ. 2025 Mar 5;388:e080952. doi: 10.1136/bmj-2024-080952.
3
Microglial Sp1 induced LRRK2 upregulation in response to manganese exposure, and 17β-estradiol afforded protection against this manganese toxicity.
小胶质细胞 Sp1 诱导 LRRK2 上调以响应锰暴露,而 17β-雌二醇则提供针对这种锰毒性的保护。
Neurotoxicology. 2024 Jul;103:105-114. doi: 10.1016/j.neuro.2024.05.007. Epub 2024 Jun 8.
4
Sex and Brain: The Role of Sex Chromosomes and Hormones in Brain Development and Parkinson's Disease.性别与大脑:性染色体和激素在大脑发育和帕金森病中的作用。
Cells. 2023 May 27;12(11):1486. doi: 10.3390/cells12111486.
5
Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson's Disease.帕金森病小鼠模型中性别和性腺状态依赖性小胶质细胞激活的三维分析
Pharmaceuticals (Basel). 2023 Jan 20;16(2):152. doi: 10.3390/ph16020152.
6
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.新冠病毒病与神经退行性疾病共有的微小RNA图谱证实神经炎症是一个重要的重叠特征。
Front Mol Neurosci. 2023 Mar 17;16:1123955. doi: 10.3389/fnmol.2023.1123955. eCollection 2023.
7
[Androgens and Parkinson's disease: the role in humans and in experiment].[雄激素与帕金森病:在人类及实验中的作用]
Probl Endokrinol (Mosk). 2022 Sep 4;68(6):146-156. doi: 10.14341/probl13148.
8
Reproductive characteristics, use of exogenous hormones and Parkinson disease in women from the E3N study.女性生殖特征、外源性激素使用与帕金森病——E3N 研究
Brain. 2023 Jun 1;146(6):2535-2546. doi: 10.1093/brain/awac440.
9
Drug reprofiling history and potential therapies against Parkinson's disease.药物重新定位的历史及针对帕金森病的潜在疗法。
Front Pharmacol. 2022 Oct 26;13:1028356. doi: 10.3389/fphar.2022.1028356. eCollection 2022.
10
State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us.更年期与激素替代疗法与帕金森病关联的临床研究现状综述:荟萃分析研究无法告诉我们的内容。
Front Aging Neurosci. 2022 Oct 20;14:971007. doi: 10.3389/fnagi.2022.971007. eCollection 2022.